MedPath

Gait Re-education Program in Subjects With Parkinson´s Disease

Not Applicable
Completed
Conditions
Parkinson Disease
Registration Number
NCT05131880
Lead Sponsor
Universidad Europea de Madrid
Brief Summary

Randomized controlled study that will include participants diagnosed with Parkinson's disease in mild or moderate stage with altered gait pattern who will be randomized following a simple randomization procedure in which one group will perform an intervention based on a gait re-education program called "TAPIZ FISIOR"- motor control and learning added to a conventional physiotherapy program; and the other group will perform only a conventional physiotherapy program. The evaluators will be unaware of the patient's treatment status.

Detailed Description

All participants interested in participating in the present study will be part of the research project. Once recruited, they will be randomly assigned to two intervention groups: A and B. Group A (control group) will perform a conventional physiotherapy treatment 2/3 sessions per week of 30 minutes duration; on the other hand, group B (intervention group) will perform the treatment of group A and a therapeutic supplement of 2-3 sessions per week of about 30 minutes. During the research period, several measurements of the variables studied will be taken: one before the intervention, one immediately after the end of the intervention, and another measurement 12 weeks after the end of the intervention.

The treatment will be carried out and supervised at all times by qualified physiotherapists, who will explain to you what the treatment consists of, the days you should attend, and the schedules. No adverse effects are expected from this therapy that could pose a risk for health.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • Older than 50 years.
  • Diagnosed Parkinson Disease.
  • Not to be institutionalized.
  • Barthel index scores of ≥ 60.
  • Ability to communicate and to get up and walk at least 10 m (33 ft)
Exclusion Criteria
  • Medical criteria for contraindication of treatment.
  • Severe behavioral problems that hinder participation in the training program.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Physical Performance: The Short Physical Performance Battery (SPPB)Before the intervention, up to 15 minutes; and at the end of 12 weeks intervention, up to 15 minutes.

The Short Physical Performance Battery (SPPB) assesses lower limb function and mobility through three subtests: standing balance (0-4), 4-m gait speed (0-4), and five-times chair rise (0-4). Subtest scores are summed for a total range of 0-12, with higher scores indicating better performance. The SPPB is widely used to detect mobility limitations, frailty, and disability risk, and has been proposed as an indicator of the mobility subdomain of intrinsic capacity.

Walk Speed: Timed Up and Go (TUG) TestBefore the intervention, up to 15 minutes; and at the end of 12 weeks intervention, up to 15 minutes.

The Timed Up and Go (TUG) test assesses basic mobility by measuring the time to stand from a chair, walk three meters, turn, return, and sit down. The time reflects walking speed, balance, turning ability, and overall functional mobility. Shorter times indicate better mobility, while longer times suggest slower gait and potential functional limitations.

Risk of Falls: FallSkipBefore the intervention, up to 10 minutes; and at the end of 12 weeks intervention, up to 10 minutes.

FallSkip is a validated tool for assessing fall risk using a portable inertial sensor placed on the lumbar spine. It evaluates parameters such as balance, gait, reaction time, and strength during standardized tasks. Results are integrated into a global score ranging from 0 (highest risk) to 100 (lowest risk), with higher scores indicating better performance and reduced fall risk.

Functionality and Independence: Barthel IndexBefore the intervention, up to 20 minutes.

The Barthel Index is a validated scale measuring functionality and independence in activities of daily living (ADLs). It assesses 10 domains including feeding, bathing, dressing, mobility, and continence. Scores range from 0 (total dependence) to 100 (complete independence). Higher scores indicate greater functional autonomy, while lower scores reflect higher dependency and care needs.

Secondary Outcome Measures
NameTimeMethod
General SatisfactionAt the end of 12 weeks intervention, up to 10 minutes.

The General Satisfaction test is used to assess participants' overall satisfaction with the intervention. Scores range from 0 to 5, where 0 indicates a very poor experience and 5 indicates an excellent experience. The scale reflects the participant's subjective evaluation of the intervention, including factors such as perceived usefulness, comfort, and outcomes. Higher scores represent greater satisfaction. This scale provides a quick and simple way to capture the overall impression of the intervention from the participant's perspective.

Trial Locations

Locations (1)

Alberto Bermejo Franco

🇪🇸

Villaviciosa de Odón, Madrid, Spain

Alberto Bermejo Franco
🇪🇸Villaviciosa de Odón, Madrid, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.